[Activation markers of the stress system in patients with type 1 diabetes during hypoglycemia].

R A Karamullina, S M Ismailova, E D Pesheva, I V Poluboyarinova, M G Poluektov, V V Fadeev
{"title":"[Activation markers of the stress system in patients with type 1 diabetes during hypoglycemia].","authors":"R A Karamullina, S M Ismailova, E D Pesheva, I V Poluboyarinova, M G Poluektov, V V Fadeev","doi":"10.14341/probl13318","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Usually, a hypoglycemic episode occurs due to inadequacy of the administered insulin dose in accordance with the current physiological situation. Activated systems aimed at increasing blood glucose levels serve as precursors of hypoglycemia and markers of the severity of hyperinsulinemia. Therefore, determining their components can serve as a more subtle and sensitive approach to assessing the physiological appropriateness of different insulin therapy options.</p><p><strong>Aim: </strong>To investigate the markers (biochemical, clinical, and morphological) and the degree of activation of the stress system preceding the development of hypoglycemic episodes in patients with type 1 diabetes (T1D) undergoing insulin therapy.</p><p><strong>Materials and methods: </strong>A cross-sectional observational clinical study was conducted involving 74 patients with type 1 diabetes (T1D). All patients underwent examination, which included assessment of the history of hypoglycemic episodes, quality of life using the SF-36 questionnaire, levels of adrenocorticotropic hormone (ACTH), insulin-like growth factor-1 (IGF-1), cortisol, C-reactive protein (CRP), coagulation profile, and 24-hour urinary cortisol excretion. Evaluation of patients' sleep characteristics was performed based on the results of completed questionnaires: Sleep Questionnaire and Epworth Sleepiness Scale. Patients underwent overnight polysomnography (PSG) with interpretation according to the AASM 2012 standards.</p><p><strong>Results: </strong>Patients with a higher frequency of hypoglycemic episodes showed a decrease in IGF-1 levels at all stages (140 [123:162]; 98 [93:121], p=0.005), worse quality of life scores across all domains of the SF-36 questionnaire (95 [88:100]; 84 [77:92], p=0.001). As the frequency of hypoglycemic episodes increased, polysomnography data revealed an increase in the number of awakenings lasting more than 3 minutes (2 [1:3]; 3 [2:4]; p=0.03), increased time spent in bed (493.1 [463.95:513.4]; 536.2 [511.6:551]; p=0.03), increased sleep duration (437.5 [430.05:468]; 489 [471.5:519], p=0.006), and in creased total sleep time (382.5 [321.75:422]; 439 [409.5:486], p=0.008).</p><p><strong>Conclusion: </strong>An increase in the frequency of hypoglycemic episodes should be accompanied by activation of the stress response system; however, repeated episodes of hypoglycemia lead to depletion of the stress response system, as evidenced by a decrease in the level of IGF-1 in patients with frequent hypoglycemic episodes. Hypoglycemic episodes occurring not only during night time but also at other times disrupt the sleep structure by increasing the frequency of nocturnal awaken ings.</p>","PeriodicalId":101419,"journal":{"name":"Problemy endokrinologii","volume":"71 2","pages":"45-54"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12117982/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Problemy endokrinologii","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14341/probl13318","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Usually, a hypoglycemic episode occurs due to inadequacy of the administered insulin dose in accordance with the current physiological situation. Activated systems aimed at increasing blood glucose levels serve as precursors of hypoglycemia and markers of the severity of hyperinsulinemia. Therefore, determining their components can serve as a more subtle and sensitive approach to assessing the physiological appropriateness of different insulin therapy options.

Aim: To investigate the markers (biochemical, clinical, and morphological) and the degree of activation of the stress system preceding the development of hypoglycemic episodes in patients with type 1 diabetes (T1D) undergoing insulin therapy.

Materials and methods: A cross-sectional observational clinical study was conducted involving 74 patients with type 1 diabetes (T1D). All patients underwent examination, which included assessment of the history of hypoglycemic episodes, quality of life using the SF-36 questionnaire, levels of adrenocorticotropic hormone (ACTH), insulin-like growth factor-1 (IGF-1), cortisol, C-reactive protein (CRP), coagulation profile, and 24-hour urinary cortisol excretion. Evaluation of patients' sleep characteristics was performed based on the results of completed questionnaires: Sleep Questionnaire and Epworth Sleepiness Scale. Patients underwent overnight polysomnography (PSG) with interpretation according to the AASM 2012 standards.

Results: Patients with a higher frequency of hypoglycemic episodes showed a decrease in IGF-1 levels at all stages (140 [123:162]; 98 [93:121], p=0.005), worse quality of life scores across all domains of the SF-36 questionnaire (95 [88:100]; 84 [77:92], p=0.001). As the frequency of hypoglycemic episodes increased, polysomnography data revealed an increase in the number of awakenings lasting more than 3 minutes (2 [1:3]; 3 [2:4]; p=0.03), increased time spent in bed (493.1 [463.95:513.4]; 536.2 [511.6:551]; p=0.03), increased sleep duration (437.5 [430.05:468]; 489 [471.5:519], p=0.006), and in creased total sleep time (382.5 [321.75:422]; 439 [409.5:486], p=0.008).

Conclusion: An increase in the frequency of hypoglycemic episodes should be accompanied by activation of the stress response system; however, repeated episodes of hypoglycemia lead to depletion of the stress response system, as evidenced by a decrease in the level of IGF-1 in patients with frequent hypoglycemic episodes. Hypoglycemic episodes occurring not only during night time but also at other times disrupt the sleep structure by increasing the frequency of nocturnal awaken ings.

[1型糖尿病患者低血糖时应激系统的激活标记物]。
背景:低血糖发作通常是由于根据当前生理情况给予胰岛素剂量不足引起的。旨在提高血糖水平的激活系统是低血糖的前兆和高胰岛素血症严重程度的标志。因此,确定它们的成分可以作为一种更微妙和敏感的方法来评估不同胰岛素治疗方案的生理适宜性。目的:探讨胰岛素治疗的1型糖尿病(T1D)患者发生低血糖发作前应激系统的生化、临床和形态学指标及激活程度。材料与方法:对74例1型糖尿病(T1D)患者进行横断面观察性临床研究。所有患者均接受检查,包括评估低血糖发作史、使用SF-36问卷评估生活质量、促肾上腺皮质激素(ACTH)水平、胰岛素样生长因子-1 (IGF-1)、皮质醇、c反应蛋白(CRP)、凝血状况和24小时尿皮质醇排泄。根据填写的睡眠问卷和Epworth嗜睡量表对患者的睡眠特征进行评估。患者接受过夜多导睡眠图(PSG),并根据AASM 2012标准进行解释。结果:低血糖发作频率较高的患者在所有阶段的IGF-1水平均下降(140 [123:162];[93:121], p=0.005), SF-36问卷各领域的生活质量得分较差(95 [88:100];[77:92], p=0.001)。随着低血糖发作频率的增加,多导睡眠图数据显示持续时间超过3分钟的觉醒次数增加(2 [1:3];3 [2:4];P =0.03),卧床时间增加(493.1 [463.95:513.4];536.2 (511.6:551);P =0.03),睡眠时间增加(437.5 [430.05:468];489 [471.5:519], p=0.006),总睡眠时间增加(382.5 [321.75:422];[409.5:486], p=0.008)。结论:低血糖发作频率的增加应伴随着应激反应系统的激活;然而,反复发作的低血糖会导致应激反应系统的耗竭,正如经常低血糖发作的患者的IGF-1水平下降所证明的那样。低血糖发作不仅发生在夜间,而且在其他时间也会增加夜间醒来的频率,从而破坏睡眠结构。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信